GE HealthCare Technologies Inc [GEHC] stock is trading at $84.90, up 2.88%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GEHC shares have gain 0.86% over the last week, with a monthly amount drifted -4.94%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
GE HealthCare Technologies Inc [NASDAQ: GEHC] stock has seen the most recent analyst activity on September 26, 2024, when UBS downgraded its rating to a Sell and also revised its price target to $74 from $84. Previously, BTIG Research upgraded its rating to Buy on September 18, 2024, and kept the price target unchanged to $100. On September 09, 2024, JP Morgan initiated with a Neutral rating and assigned a price target of $90 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $100 on August 06, 2024. Goldman initiated its recommendation with a Neutral and recommended $87 as its price target on May 30, 2024. HSBC Securities started tracking with a Buy rating for this stock on February 15, 2024, and assigned it a price target of $100. In a note dated February 12, 2024, UBS upgraded an Neutral rating on this stock and boosted its target price from $66 to $88.
GE HealthCare Technologies Inc [GEHC] stock has fluctuated between $66.39 and $94.55 over the past year. Currently, Wall Street analysts expect the stock to reach $93.9 within the next 12 months. GE HealthCare Technologies Inc [NASDAQ: GEHC] shares were valued at $84.90 at the most recent close of the market. An investor can expect a potential return of 10.6% based on the average GEHC price forecast.
Analyzing the GEHC fundamentals
GE HealthCare Technologies Inc [NASDAQ:GEHC] reported sales of 19.56B for the trailing twelve months, which represents a growth of 0.85%. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.22 and Total Capital is 0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 83.11 points at the first support level, and at 81.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 85.99, and for the 2nd resistance point, it is at 87.08.
Ratios To Look Out For
For context, GE HealthCare Technologies Inc’s Current Ratio is 1.19. As well, the Quick Ratio is 0.94, while the Cash Ratio is 0.41. Considering the valuation of this stock, the price to sales ratio is 1.98, the price to book ratio is 4.66 and price to earnings (TTM) ratio is 23.25.
Transactions by insiders
Recent insider trading involved Rott Roland, CEO, Imaging, that happened on Nov 06 ’24 when 3577.0 shares were sold. Officer, Roland Rott completed a deal on Nov 06 ’24 to buy 3577.0 shares. Meanwhile, Officer Philip Rackliffe bought 900.0 shares on Nov 05 ’24.
